Transcatheter Mitral Valve Replacement in High-Surgical Risk Patients: A Single-Center Experience and Outcome.

Fatma Aboalsoud TahaHesham NaeimFareed AlnozhaOsama AmoudiReda Abuelatta

Published in: Journal of interventional cardiology (2022)

TMVR is a feasible and safe approach in patients with high surgical risk. TMViV and TMViR are reasonable as the first treatment approaches, and TMViMAC seems encouraging.

Keyphrases

mitral valve
end stage renal disease
ejection fraction
chronic kidney disease
left atrial
combination therapy
replacement therapy